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Abstract
Background: Oral rehydration solution (ORS) is a simple intervention that can prevent childhood deaths from
severe diarrhea and dehydration. In a previous study, we mapped the use of ORS treatment subnationally and
found that ORS coverage increased over time, while the use of home-made alternatives or recommended home
fluids (RHF) decreased, in many countries. These patterns were particularly striking within Senegal, Mali, and Sierra
Leone. It was unclear, however, whether ORS replaced RHF in these locations or if children were left untreated, and
if these patterns were associated with health policy changes.
Methods: We used a Bayesian geostatistical model and data from household surveys to map the percentage of
children with diarrhea that received (1) any ORS, (2) only RHF, or (3) no oral rehydration treatment between 2000
and 2018. This approach allowed examination of whether RHF was replaced with ORS before and after
interventions, policies, and external events that may have impacted healthcare access.
Results: We found that RHF was replaced with ORS in most Sierra Leone districts, except those most impacted by
the Ebola outbreak. In addition, RHF was replaced in northern but not in southern Mali, and RHF was not replaced
anywhere in Senegal. In Senegal, there was no statistical evidence that a national policy promoting ORS use was
associated with increases in coverage. In Sierra Leone, ORS coverage increased following a national policy change
that abolished health costs for children.
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Conclusions: Children in parts of Mali and Senegal have been left behind during ORS scale-up. Improved
messaging on effective diarrhea treatment and/or increased ORS access such as through reducing treatment costs
may be needed to prevent child deaths in these areas.
Keywords: Oral rehydration solution, Recommended home fluids, Oral rehydration therapy, Diarrhea, Health
policies, Spatial analysis, Geospatial modeling
Background
Oral rehydration solution (ORS) is a type of oral rehy-
dration therapy that can prevent deaths from severe
diarrhea and dehydration in children [1]. It is most com-
monly sold as pre-made packets with standard amounts
of sodium and glucose and is properly prepared by dis-
solving the solution in 1 L of clean water. It has been
promoted by the World Health Organization (WHO)
and the United Nations Children’s Fund (UNICEF) as an
essential medicine to treat diarrhea since it was discov-
ered over 50 years ago [2]. Access to and use of ORS,
however, are low globally [3].
Recommended home fluids (RHF) are home-made
types of oral rehydration therapy (ORT), which can in-
clude sugar-salt solutions, cereal-salt solutions, juice, rice
water, tea, or coconut water [1]. In the 1980s, the WHO
promoted the use of RHF as home-made alternatives to
ORS [2]. However, RHF were broadly defined and it was
unclear whether they were effective at preventing diar-
rheal deaths [1]. Thus, the WHO stopped recommend-
ing RHF in 1991 and ORS remains the recommended
rehydration treatment for severe diarrhea according to
UNICEF, the WHO, and the US Centers for Disease
Control and Prevention [4, 5].
In a previous geospatial analysis, we found that the use
of ORS increased and the use of RHF decreased between
2000 and 2017 in various low- and middle-income coun-
tries (LMICs) at both national and subnational levels [6].
These patterns were particularly striking in subnational
areas of Sierra Leone, Mali, and Senegal, countries where
diarrhea mortality rates remain high and effective diar-
rhea treatment is critical to save child lives [7]. It was
possible that ORS use replaced RHF use within these
countries; alternatively, these trends could indicate some
children with diarrhea had been treated with ORS, while
others had transitioned from treatment with RHF to no
ORT. An important limitation of that analysis was that
we did not focus on why there were changes in
treatment.
Previous work in these and other countries has add-
itionally shown that ORS scale-up is impacted by factors
such as ORS cost, accessibility, knowledge, and local cul-
ture [3, 8]. To date, however, no study had specifically
examined the relationship between ORS and RHF sub-
nationally temporally in the context of changing health
policies and events that impact those factors. Under-
standing changes in treatment is critical to ending pre-
ventable child deaths from severe diarrhea and
dehydration.
In order to examine the basis of these trends, we first
mapped the use of ORT across second administrative-
level units (e.g., districts) in Sierra Leone, Mali, and
Senegal to determine if RHF was replaced by ORS, or if
RHF was not replaced and hence there were children left
completely untreated. Then, in order to understand the
broader impact of intervention scale-up on diarrhea
treatment and, ultimately, on child survival, we explored
whether changes in ORT occurred before or after inter-
ventions, changes to healthcare policy, or access. If chil-
dren were left behind—not yet receiving ORS and no
longer receiving RHF—improved access or messaging re-
garding effective diarrhea treatment may be needed to
prevent deaths in affected districts.
Adapting the Bayesian geostatistical methods from our
previous study [6], we estimated the percent of children
that received three diarrhea treatments (any ORS, only
RHF, and no ORT) from 2000 to 2018 at the district/
cercle/department level in Sierra Leone, Mali, and
Senegal, respectively. To our knowledge, this represents
the first spatial analysis of changes in ORT over time in
the context of changing policies and access to
healthcare.
Methods
The study locations, data sources, spatial covariates, and
statistical analyses for this study are consistent with
those employed in our previous study [6], with a few
modifications. First, we restricted the analysis to just
three countries: Senegal, Sierra Leone, and Mali. We se-
lected these countries because each (1) had experienced
changes in ORS and/or RHF during the study period [6],
(2) had implemented policies or interventions aimed at
improving ORS coverage during the study period (see
the “Analysis of policy changes” section below), and (3)
had at least 6 years of survey data available. Second, we
created mutually exclusive and collectively exhaustive
ORT indicators such that each child was placed into
exactly one of three categories (any ORS, only RHF, and
no ORT). Third, we ran models separately for each
country and restricted models to run from the first to
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the last year of study data. These methods are described
below, with further details in Additional file 1 [9–26].
Survey data
We collected data from national, population-based
household surveys—including Demographic Health
Surveys and UNICEF Multiple Indicator Surveys—in
which primary sampling units (PSU) could be geo-
located below the country level. We included data from
child modules where mothers were asked whether their
children under 5 years of age had diarrhea in the past
2 weeks and, if so, whether they received ORS and/or
RHF. In these surveys, diarrhea is defined as three or
more loose or watery stools in a 24-h period, which
corresponds to acute diarrhea (henceforth referred to as
“diarrhea”). In total, we included six surveys in Sierra
Leone (years 2000–2017), six surveys in Mali (2001–
2018), and nine surveys in Senegal (2000–2017)
(Additional file 1: Table S2).
Treatment categories
We determined the percentage of children with diarrhea
in each PSU that received (1) any ORS treatment (“any
ORS,” which included treatment with only ORS, or with
ORS and RHF), (2) only RHF treatment (“only RHF”), or
(3) no oral rehydration treatment (“no ORT,” not treated
with ORS or RHF) by taking the population-weighted
mean of all children sampled within that PSU.
We employed methods from our previous study to ad-
just for differences in RHF definitions and survey ques-
tions from 2000 to 2018 [6]. In brief, RHF questions
were classified as including options of (1) recommended
or acceptable home fluids, (2) sugar and salt solutions,
(3) other home fluids, and/or (4) other liquid foods. We
fitted a logistic regression model to surveys across all
LMICs, regressing coverage on definition, country-level
fixed effects, and a natural cubic spline on survey year.
The global adjustment factor for each non-standard
definition (including options other than “recommended
or acceptable home fluids”) was the coefficient of the fixed
effect for that definition. Coverage reported by non-
standard surveys was multiplied by the adjustment factor
in logit space (Additional file 1: Tables S3 and S4).
Statistical analyses
Analyses were carried out using R version 3.5.0. Cover-
age of any ORS, only RHF, and no ORT were modeled
independently using the Bayesian model-based geostatis-
tical framework from our previous ORT study [6]. Simi-
lar methodological details are available from additional
previous mapping work [27–29]. Briefly, this framework
used a hierarchical logistic regression model to predict
coverage on a continuous surface, assuming similar
coverage in locations closer together in space and time
and with similar covariate patterns. Potential non-linear
relationships between covariates (Additional file 1: Sec-
tion 2.4) and coverage were incorporated through
stacked generalization [30]. Posterior distributions of all
model parameters and hyperparameters were estimated
using R-INLA version 19.05.30.9000.30 [31]. Coverage
estimates were obtained by taking 1000 draws from the
posterior distribution and were adjusted by draw to
ensure that the three categories summed to 1 in each
location-year:
Any ORSadjusted ¼ Any ORSAny ORSþ only RHF
 1 − no ORTð Þ
Only RHFadjusted ¼ Only RHFOnly RHFþ any ORS
 1 − no ORTð Þ
We calculated population-weighted aggregations of
the 1000 draws by country and second administrative-
level unit. Mean estimates are reported with 95% uncer-
tainty intervals, which represent the 2.5th and 97.5th
percentiles of the 1000 draws. All estimates are reported
in Additional file 1: Tables S9–S11 and Additional file 2,
with corresponding maps of mean estimates in Add-
itional file 1: Figure S5–S6.
Analysis of policy changes
We conducted a non-systematic literature search to
identify changes in health policies, interventions, or
events that may have impacted ORS scale-up within
each country during the study period. We initially
searched Google and PubMed with broad terms such as
“Senegal” and “oral rehydration,” or “Senegal” and
“diarrhea treatment.” We reviewed research articles,
policy reports, news articles, and their references. Based
on the initial findings, we modified and expanded our
initial search until we exhausted the information we
could find.
We synthesized and discussed the findings with in-
country experts, whom we identified through contacts in
the Global Burden of Disease Collaborator Network. We
created a report for each country that included (1) study
methodology, (2) summary of key dates and data
sources, and (3) preliminary results. In each interview,
we (1) discussed the content of the report, (2) answered
any questions they had, and (3) asked questions about
whether there were key events and/or additional context
surrounding changes in diarrhea treatment and access to
healthcare at national or subnational levels that should
be taken into account.
For the final analysis, we focused on two major events
in each country, which are described below with add-
itional details on all policies, programs, and events in the
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study period in Additional file 1: Section 5.0. The time
periods for analysis were selected based on (1) the
date(s) that the policy, intervention, or event occurred;
(2) years for which we had data available to inform the
estimates; and (3) deliberation among co-authors. For
ease of interpretation, we set the time periods to start
and end at the mid-point of each year (i.e., July 2).
In Sierra Leone, key events were a national policy im-
plemented in 2010 to make healthcare free for pregnant
women, new mothers, and children [32], and the Ebola
outbreak from 2014 to 2016 [33] (Additional file 1:
Section 5.1). We examined ORT changes during three
periods: (1) July 2, 2000–July 1, 2009, before policy
changes; (2) July 2, 2009–July 1, 2013, comprising policy
changes; and (3) July 2, 2013–July 1, 2017, comprising
the outbreak.
In Mali, key events were interventions in southern
Mali between 2003 and 2004 that introduced ORS and
zinc therapy in Bougouni [34, 35] and established mu-
tual health organizations in Bla and Sikasso [36], and the
war in North Mali in 2012 [37] (Additional file 1: Sec-
tion 5.2). We examined ORT changes from (1) July 2,
2001–July 1, 2004, during intervention implementation;
(2) July 2, 2004–July 1, 2011, following the interventions;
and (3) July 2, 2011–July 1, 2018, comprising the war.
In Senegal, key events were a national policy imple-
mented in 2008 to promote combined ORS and zinc
treatment for diarrhea [38], and a national ORS and zinc
intervention launched in 2012 [39, 40] (Additional file 1:
Section 5.3). We examined ORT changes from (1) July 2,
2000–July 1, 2006, before policy changes; (2) July 2,
2006–July 1, 2012, comprising policy changes; and (3)
July 2, 2012–July 1, 2017, during the intervention.
Analysis of changes over time
We analyzed changes over time in three distinct ways
within each country. First, we described the absolute
change in coverage of ORS and RHF within each time
period (Additional file 1: Table S10). We compared re-
sults by location and year using mean and 95% uncer-
tainty intervals. Second, we examined the annual rate of
change in coverage (Additional file 1: Table S11). We
calculated these rates at the draw-level to assess whether
or not there was a high probability (posterior probability
> 95%) that coverage increased or decreased within each
second administrative-level unit and time period.
Finally, we examined whether or not the use of RHF
was replaced with the use of ORS. RHF was considered
not replaced when more than 95% of draws (posterior
probability > 95%) showed that decreases in “only RHF”
were greater than increases in “any ORS” (i.e., the per-
cent of children that received no ORT increased). RHF
was considered replaced when more than 95% of draws
showed that the percent of children that received no
ORT decreased.
Numbers of untreated children
Numbers of untreated children with diarrhea were draw-
level estimates of treatment coverage at the second
administrative-level unit multiplied by mean childhood
diarrhea prevalence [7] and by the number of children
under the age of 5 [41]. Numbers of children that did
not receive any ORS in 2017/2018, but would have re-
ceived some form of ORT in 2000/2001, were calculated
by multiplying the number untreated with ORS in 2017/
2018 by ORT coverage (or, 1 – “no ORT”) in 2000/2001.
Results
National and subnational (district-level) trends in Sierra
Leone
In Sierra Leone, ORS use increased from 51.8% (48.1–
55.5) to 77.4% (74.2–80.3) between 2000 and 2017 and
exceeded RHF use to treat diarrhea, resulting in a de-
crease in the percent of children receiving no ORT from
35.8% (32.0–40.0) to 21.1% (18.0–24.2) (Fig. 1a, Add-
itional file 1: Table S9a). Therefore, RHF was completely
replaced with ORS at the national level (Fig. 1a).
Before a national health policy was implemented in
2010, five districts located in northern Sierra Leone had
the lowest ORS coverage in 2000 (ranging from 32.7%
(25.3–40.7) to 41.1% (34.8–48.3) coverage) and showed
the largest improvements in ORS use by 2009 (55.8%
(68.0–78.6) to 74.4% (64.5–82.8)) (Fig. 2a, Add-
itional file 1: Table S10a). Decreases in RHF were small
(Fig. 2b) and, by 2009, all northern districts had replaced
their RHF use (Fig. 2c). Western, southern, and eastern
districts showed increases in ORS use after health costs
were abolished for pregnant women, new mothers, and
children in 2010 (Fig. 2a). Before the policy, only one of
seven southern and eastern districts showed a high
probability (posterior probability > 95%) of increased
ORS use. In the period comprising the policy change
(2009–2013), ORS use increased in all seven southern
and eastern districts (Additional file 1: Table S11a),
replacing RHF by 2012 (Fig. 2d).
From 2013 to 2017, during and after the 2014–2016
Ebola outbreak, we found country-wide decreases in
ORS coverage (Fig. 2a), with high probability of de-
creases in four of five northern districts, two of two
western districts, and one of seven southern and eastern
districts (Additional file 1: Table S11a). Sierra Leone’s
Western districts saw the greatest decreases, with
Western Area Urban (comprising the capital, Freetown)
decreasing from 84.8% (79.3–89.1) to 69.2% (60.2–76.7)
coverage (Fig. 2a). Western Area Urban also saw the
greatest number of Ebola cases in the years 2014 and
2015 [33]. In addition, we found that RHF coverage
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increased in Western districts in this period, but these
increases were smaller than decreases in ORS (Fig. 2b,
Additional file 1: Table S11). By 2017, RHF was no lon-
ger replaced in Western Area Urban and Rural districts
(Fig. 2c).
National and subnational (cercle-level) trends in Mali
In Mali, ORS use increased nationally from 14.4% (11.8–
17.0) to 23.0% (20.5–25.6) between 2001 and 2018 and
almost replaced RHF use. The percent of children re-
ceiving no ORT changed very little in this time period,
from 69.3% (67.0–71.3) to 72.7% (70.3–75.2) (Fig. 1b,
Additional file 1: Table S9b). A spike in ORS coverage
occurred in 2012 (Fig. 1b), but this should be interpreted
with caution as data were not collected in north Mali
during the war in 2012.
Subnationally, we found very little change in ORS cover-
age between 2001 and 2004, including cercles in southern
Mali where interventions were implemented (Fig. 3a). In
Bougouni, ORS coverage changed from 13.7% (8.6–19.8)
to 16.5% (4.1–36.8), in Sikasso from 16.7% (10.4–24.5) to
17.2% (3.8–42.6), and in Bla from 21.5% (13.2–31.8) to
15.7% (3.3–38.3) (Fig. 3a). ORS coverage increased in
northern Mali during this time period (Fig. 3a), although
uncertainty around these estimates was high (Add-
itional file 1: Table S10b). Northern cercles had low ORS
coverage in 2001 (ranging from 3.3% (1.1–6.4) to 14.5%
(7.2–24.8) coverage), and by 2004 had similar coverage to
most southern cercles (11.1% (2.2–27.0) to 16.2% (4.1–
40.6)). By 2004, RHF had been replaced in three of 21
northern cercles and had not been replaced in four of 28
southern cercles (Fig. 3c).
In the period following the interventions (2004–2011),
we found little change in ORT coverage throughout
Mali. Larger changes occurred between 2011 and 2018,
which comprised the war (Fig. 3a, b). By 2018, 6 years
after the war in north Mali, decreases in RHF (Fig. 3b)
were replaced by increases in ORS in 16 of 21 northern
cercles and three of 28 southern cercles (Fig. 3d). RHF
was not replaced in 12 of 28 southern cercles or in
Bamako (Fig. 3d).
National and subnational (department-level) trends in
Senegal
In Senegal, the proportion of children with diarrhea that
received ORS increased from 13.0% (10.0–16.6) to 27.1%
(23.4–30.7) between 2000 and 2017 (Fig. 1c, Add-
itional file 1: Table S9c). The decrease in the proportion
of children that received RHF, however, exceeded the
increase in ORS and the proportion of children receiving
no ORT increased from 52.3% (48.0–56.6) to 70.3%
(66.5–74.0) (Fig. 1c, Additional file 1: Table S9c). There-
fore, RHF was not replaced with ORS at the national
level (Fig. 1c).
Fig. 1 National-level changes in the use of different oral rehydration
therapies to treat childhood diarrhea. a Changes in Sierra Leone
from 2000 to 2017. b Changes in Mali from 2001 to 2018. c Changes
in Senegal from 2000 to 2017. Coverage of any oral rehydration
solution (“any ORS,” which included treatment with only ORS or with
ORS and RHF) is shown in green; only recommended home fluids
(only RHF) is in yellow, and no oral rehydration therapy (no ORT) is
in purple. Coverage is defined as the percent of children with
diarrhea that fell into each category. Results represent the
population-weighted mean of estimates aggregated to the national
level. See Additional file 1: Table S9 for corresponding mean
estimates and uncertainty intervals
Wiens et al. BMC Medicine          (2020) 18:405 Page 5 of 13
Most changes in ORT occurred between 2000 and
2006, before promotion and implementation of com-
bined ORS and zinc treatment for diarrhea, and there
was limited variation between departments (Fig. 4a, b,
Additional file 1: Table S10c). Increases in ORS were
small, ranging from between 9.5% (6.1–14.0) and
21.6% (16.1–29.5) coverage in 2000 to between 18.8%
(12.4–24.4) and 26.2% (19.2–34.9) coverage in 2006
(Fig. 4a). Decreases in RHF were large, ranging from
between 26.4% (18.9–32.4) and 41.3% (32.8–50.6)
coverage in 2000 to between 5.0% (2.6–8.3) and
10.7% (5.4–17.8) coverage in 2006 (Fig. 4b). Thus,
RHF had not been replaced in any department by
2006 (Fig. 4c).
During the periods comprising the policy change
(2006–2012) and the intervention (2012–2017), mean
ORS coverage continued to increase while RHF de-
creased in most departments (Fig. 4a, b). While 28 of
Senegal’s 45 departments showed high probability of im-
provement between 2000 and 2006, however, none
showed high probability of improvement after 2006
(Additional file 1: Table S11c). By 2017, RHF had still not
been replaced with ORS in 44 of Senegal’s 45 departments
(Fig. 4d).
Numbers of untreated children
In the previous analyses, we found that Senegal and Mali
each contain areas where decreases in RHF coverage
Fig. 2 Changes over time in oral rehydration therapies by district in Sierra Leone. a, b Percent of children that received any ORS (a) or only RHF
(b) at four time points during the study: start of the study (2000); before national policy was implemented to abolish health costs for children,
pregnant women, and new mothers (2009); 3 years after policy change (2013); and 2 years after the Ebola epidemic (2017). The western districts
saw the greatest number of Ebola cases. Colored bands show the range of the mean estimates across northern districts in orange, southern and
eastern districts in blue, and western urban (or Freetown) and western rural districts in brown. Note that in order to clearly illustrate trends in ORS
and RHF, scales on the y-axis differ between panels a and b. In addition, in order to focus on changes within three distinct time periods, the
x-axis is not to scale by year. c–e RHF replacement by district from 2000 to 2009 (c), 2000 to 2013 (d), and 2000 to 2017 (e). Districts with > 95%
posterior probability that RHF was replaced by ORS are shown in green. Light green indicates RHF was replaced by the indicated date, and dark
green indicates RHF had already been replaced by the previous date. Districts where our estimates had higher uncertainty (< 95% posterior
probability that RHF was either replaced or not replaced) are shown in light purple. Panel e corresponds to the region within the dashed inset in
panel d and illustrates that RHF was no longer replaced in Western districts by 2017
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were not replaced with increases in ORS coverage (Figs. 3
and 4) and numbers of untreated children remained high
(Additional file 1: Figure S6). In order to estimate the
numbers of children that have potentially been left be-
hind during ORS scale-up efforts, we compared the
number of children that remained untreated with ORS
at the end of the study with the number of children that
would have received any form of ORT (ORS and/or
RHF) at the beginning of the study (Fig. 5).
In Mali, we found that 87,530 (84,580–90,360) chil-
dren with diarrhea did not receive ORS in 2018 (Fig. 5a,
Additional file 1: Table S9b). Of these, 26,900 (24,280–
29,830) would have received some form of ORT if
coverage maintained 2001 levels (Fig. 5b). Numbers were
highest in the capital of Bamako; in Kati Cercle, Kouli-
koro Region; and in Kayes Cercle, Kayes Region (Fig. 5b).
In Senegal, 77,780 (73,920–81,640) children with
diarrhea did not receive ORS in 2017 (Fig. 5c, Add-
itional file 1: Table S9c). Of these, 37,130 (32,100–42,
420) would have received some form of ORT if coverage
were at 2000 levels (Fig. 5d). Numbers were highest in
Pikine Department, Dakar Region; in Mbacké Depart-
ment, Diourbel Region; and in the capital of Dakar
(Fig. 5d). These represent areas where a large number of
children may have been left behind during ORS scale-up
efforts.
Fig. 3 Changes over time in oral rehydration therapies by cercle in Mali. a, b Percent of children that received any ORS (a) or only RHF (b) at four
time points during the study: before interventions were implemented in south Mali (2001), 1 year after interventions (2004), 8 years after
interventions (2011), and 6 years after the war in North Mali (2018). Colored bands show the range of the mean estimates across northern cercles
in orange, southern cercles in blue, and the capital city Bamako in brown and highlighted with a star. Note that in order to clearly illustrate
trends in ORS and RHF, scales on the y-axis differ between panels a and b. In addition, in order to focus on changes within three distinct time
periods, the x-axis is not to scale by year. c, d RHF replacement by cercle from 2001 to 2004 (c) and 2001 to 2018 (d). Cercles with > 95%
posterior probability that RHF was replaced by ORS are shown in green. Light green indicates RHF was replaced by the indicated date, and dark
green indicates RHF had already been replaced by the previous date. Cercles where there was greater than 95% posterior probability that RHF
was not replaced are shown in darker purple. Cercles where our estimates had higher uncertainty (< 95% posterior probability that RHF was
either replaced or not replaced) are shown in light purple. Cercles with > 95% posterior probability that RHF was not replaced by ORS are shown
in dark purple
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Discussion
This study shows, for the first time, how ORS and RHF
treatments have changed in the context of changing health
policies and interventions. This expands on previous find-
ings that Sierra Leone was a “sustained success” in ORS
scale-up, while Senegal and Mali were “non-starters” [3].
Sierra Leone
In Sierra Leone, northern districts—which on average
are estimated to have greater travel times to urban cen-
ters than southern and eastern districts [42]—had the
lowest ORS use in 2000 and showed the greatest in-
creases in ORS from 2000 to 2009. In comparison,
southern and eastern districts that had higher ORS
coverage in 2000 showed slower progress until 2010,
when health costs were abolished for children, pregnant
women, and new mothers [32], which increased health-
care utilization [43]. This may reflect a positive effect of
low-cost access to healthcare on ORS scale-up.
ORS use to treat diarrhea decreased in northern and
western districts during the Ebola outbreak (2014–2016)
[33], which decreased healthcare utilization [44]. This
change was largest in the capital of Freetown, the only
district where RHF use was not replaced with ORS by
2017. Northern and western districts may be more sus-
ceptible to changes in access to ORS during disruptions
to healthcare, such as the Ebola outbreak. In southern
and eastern Sierra Leone, increased access to urban cen-
ters [42, 45] and larger amounts of foreign aid after the
civil war [46] may have contributed to the relatively
higher and more stable ORS coverage, as well as lower
diarrhea prevalence [7].
Fig. 4 Changes over time in oral rehydration therapies by department in Senegal. a, b Percent of children that received any ORS (a) or only RHF
(b) at four time points during the study: start of the study (2000), before the policy change to promote improved ORS and zinc as diarrhea
treatment (2006), 6 years after the policy change (2012), and 5 years after the launch of the national ORS and zinc scale-up intervention (2017).
Colored bands show the range of the mean estimates across northern departments in brown, south-western departments in blue, and the rest of
the departments in orange. These divisions were chosen to highlight the largest differences between departments in 2000. Note that in order to
clearly illustrate trends in ORS and RHF, scales on the y-axis differ between panels a and b. In addition, in order to focus on changes within three
distinct time periods, the x-axis is not to scale by year. c, d RHF replacement by department from 2000 to 2006 (c) and 2000 to 2017 (d).
Departments with > 95% posterior probability that RHF was not replaced by ORS are shown in darker purple. Departments where our estimates
had higher uncertainty (< 95% posterior probability that RHF was either replaced or not replaced) are shown in light purple
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Mali
In Mali, we found small increases in ORS coverage in
the north, which had extremely low coverage rates in
2000. Northern Mali is part of the Sahel desert, a region
comprised largely of nomadic groups [47] with limited
access to clean water, healthcare, and education, as well
as widespread hunger and malnutrition [48]. Along with
parts of Mopti in central Mali, it saw massive displace-
ment and violence during the 2012 war [37] and con-
tinues to experience frequent conflict. It is unsurprising
that diarrhea prevalence is high [7] and ORS coverage is
low in a region with such serious security problems.
An additional barrier to ORS scale-up is insufficient
access to healthcare throughout Mali. Treatments are
generally mediated through community healthcare
workers, of which there were only an estimated 2.7
workers per 10,000 people in 2007 [49]. In addition, al-
though ORS is promoted through radio, television, and
child survival interventions, it is often only considered
with other therapies due to the time and expense of
seeking treatment [49] and the knowledge that ORS does
not cure diarrhea [35].
Senegal
In Senegal, we found substantial decreases in RHF, with
relatively small increases in ORS, such that many chil-
dren went untreated with ORT in all districts. From
2000 to 2006—which saw the greatest decreases in
RHF—a variety of USAID “technical assistance” pro-
grams were implemented across the country to intro-
duce ORS through “health huts” and integrated
community care management [38, 50]. The ORS prices
were marked up in order to cover supply costs [51], sug-
gesting that these programs increased ORS awareness
without commensurately increasing access. Similar re-
sults have been found in other intervention contexts. A
study on insecticide-treated bednets in Madagascar
Fig. 5 Number of children with diarrhea that were untreated with oral rehydration therapies. a Number of children with diarrhea that did not
receive any ORS by cercle in Mali in 2018. b Number of children in Mali in 2018 that did not receive any ORS, but would have received ORT (ORS
and/or RHF) if coverage were at 2001 levels. c Number of children with diarrhea that did not receive any ORS by department in Senegal in 2017.
d Number of children in 2017 in Senegal that did not receive any ORS, but would have received ORT (ORS and/or RHF) if coverage were at 2000
levels. Panels b and d show units with > 95% posterior probability that RHF was not replaced by ORS; all other units are masked in gray.
Numbers of children with diarrhea were determined using previous estimates of mean diarrhea prevalence in 2017 [7]
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found that when prices increased by $0.55, coverage fell
by 23.1% points [52].
We found no evidence for associations between
changes in diarrhea treatment policy [38] or ORS and
zinc scale-up programs [39, 40] and changes in ORT in
Senegal. Previous work discussed how weak distribution
systems, lack of knowledge of ORS, treatment cost, and
reliance on external funders have contributed to slow
ORS uptake in Senegal [3]. Additionally, about a third of
Senegal’s population utilize private pharmacies [53],
which may under-prescribe ORS [54]. Moreover, a 2011
study—conducted after a pilot ORS and zinc interven-
tion was implemented in Dakar, Diourbel, and St.
Louis—reported that home-made solutions were the
preferred treatment for childhood diarrhea [55]. This is
in contrast to Sierra Leone’s success, which has been at-
tributed to strong community-based support for ORS
treatment since the civil war [3].
Implications for policy
Our results suggest that national-level policies promot-
ing ORS are necessary but not sufficient for ORS scale-
up. Policies must be combined with efforts to make ORS
affordable and widely available. Sierra Leone succeeded
in combining these strategies, while Senegal imple-
mented a policy without increasing access. The decrease
in ORS coverage during the Ebola outbreak in north-
western Sierra Leone and the overall low coverage in
Mali additionally highlight the importance of stability for
ensuring access.
The importance of free or affordable access to
healthcare for ORS scale-up is supported by previous
work. A trial in Uganda found that providing free and
convenient ORS packets increased coverage by 19%
points compared to controls [56]. The governments
of Senegal and Mali have each committed to extend-
ing free healthcare to pregnant women and children
by 2022 [57, 58]. If implemented successfully, these
programs could make important progress toward re-
ducing diarrheal deaths in children.
In all three countries, it will continue to be critical to
educate caregivers about diarrhea causes, symptoms, and
effective treatment. In rural Mali, mothers knew of ORS
but sought other cures, such as antibiotics, traditional
medicines, or malaria pills [35]. In Mbour, Senegal, only
23.2% of caregivers showed good management of diar-
rhea [59], while in Dakar, Diourbel, and St. Louis, only
29–54% knew of ORS and zinc treatment [55]. In con-
trast, 94.1% of mothers in rural Sierra Leone knew of
ORS and its use to treat diarrhea [60]. Only 43.9%, how-
ever, had overall knowledge of diarrhea management,
and only 39.0% knew the procedure for preparing RHF
when ORS was not available [60]. In addition, in Sierra
Leone, ORS is often used for conditions it is not
intended to treat (Carrie Jo Cain, personal communica-
tion). This illustrates the complexity in education around
diarrhea treatment and the importance of further work
in this area.
Limitations
This study has several limitations. Our models were op-
timized for prediction, not for causal inference. Thus,
our aim was to describe patterns rather than evaluate
causal impacts of policies or covariates on treatment
changes. In addition, we did not have data in Sierra
Leone immediately after the Ebola outbreak in 2015 and
2016, in Senegal from 2001 to 2005, or in northern Mali
in 2012, so we were unable to capture data-driven vari-
ation in these years. Data quality also varied between
surveys and locations. For example, in Mali, there was
greater heterogeneity in the data compared with Senegal
and Sierra Leone. This led to comparatively lower pre-
dictive validity (Additional file 1: Figure S2-S4), higher
uncertainty (Additional file 1: Tables S9-S11), and many
locations where we could not confidently estimate
whether or not RHF was replaced with ORS (Fig. 3c, d).
For this reason, we focused the final analysis of numbers
of children left behind on subnational locations where
uncertainty in our estimates was lower (Fig. 5). Though,
in this latter analysis, we could not propagate uncer-
tainty for numbers of children with diarrhea [7, 41].
Finally, survey data reported ORS and RHF use to treat
diarrhea, but we cannot make conclusions about effect-
ive coverage, such as whether the solutions were pre-
pared correctly. Similarly, the survey data did not
include symptoms stratified by disease severity and we
were not able to evaluate whether it was used appropri-
ately to treat severe diarrhea and dehydration.
Future work
Additional studies are needed on how health system
functionality, treatment supply, and co-coverage of other
interventions are associated with effective diarrhea treat-
ment and reductions in child deaths. Our previous work
showed that annualized rates of decline in childhood
diarrhea mortality were similar in Sierra Leone,
Senegal, and Mali (with high levels of uncertainty)
[7]. Studies that develop inferential approaches, and
integrate new data sources, could examine how inter-
ventions other than ORS have driven declines in Mali
and Senegal and the best ways to reduce mortality
further in Sierra Leone.
Similarly, in this study, we were not able to examine
how subnational patterns in ORS coverage compared
with patterns in joint ORS-zinc treatment. UNICEF’s lat-
est data show that ORS-zinc treatment for diarrhea has
increased nationally in Senegal from 0% (2011) to 18%
(2017), in Mali from 2% (2012) to 9% (2018), and in
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Sierra Leone from 3% (2013) to 43% (2017) [61]. As
more data become available and additional countries
adopt policies promoting joint ORS-zinc therapy, map-
ping ORS-zinc coverage will be an important extension
of this work.
Finally, these analyses could be applied to additional
diseases and interventions. Subnational estimates of
lower respiratory infections, malaria, HIV, and other
health risks are publicly available and can be explored
using interactive online visualization tools [62]. We en-
courage other investigators to use these data for similar
retrospective studies.
Conclusions
Our results show that districts with low ORS coverage
in Mali, Sierra Leone, and Senegal have tended to
quickly catch up with districts of higher coverage.
Significant health policy changes such as abolishing
health costs, however, may be needed to increase cover-
age further. We also show that events such as conflict
and the Ebola outbreak likely negatively impact ORS ac-
cess. Effective messaging regarding appropriate diarrhea
treatment could save child lives during these destabiliz-
ing events, as well as in locations where ORS has not yet
replaced RHF. These expanded efforts will be critical to
reach the over 150,000 children with diarrhea that do
not receive ORS in Mali and Senegal.
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